Cancer Family
Pancreaticobiliary Neoplasm
CI-CAN-00000309Explore in graph →
Non-malignant1,204 active trials11 approved drugs92 evidence items
- NCIt
- C223357
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000309Explore in graph →
Clinical trials
5,004 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00898781 | Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | terminated | — | 80 | Mayo ClinicOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00658801 | Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma | terminated | Phase 1 | 4 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00415454 | Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma | terminated | Phase 1 | 8 | Henry Ford Health SystemOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00550004 | Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine(RP101) | terminated | Phase 2 | 153 | SciClone PharmaceuticalsINDUSTRY | 13 | Jun 8, 2011 | clinicaltrials |
| NCT00326911 | Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer | terminated | Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 1 | May 25, 2011 | clinicaltrials |
| NCT00428597 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | terminated | Phase 3 | 171 | PfizerINDUSTRY | 11 | Oct 11, 2010 | clinicaltrials |
| NCT00014651 | Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection | terminated | Phase 3 | — | Mayo ClinicOTHER | 1 | Aug 10, 2010 | clinicaltrials |
| NCT00177853 | Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer | terminated | Phase 1 | 23 | University of PittsburghOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00005997 | Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer | terminated | Phase 2 | 72 | Case Comprehensive Cancer CenterOTHER | 1 | Jun 11, 2010 | clinicaltrials |
| NCT00540735 | Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas(CK/PDT) | terminated | Phase 3 | 80 | University Hospital, AngersOTHER_GOV | 1 | Feb 4, 2010 | clinicaltrials |
| NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 52 | Massachusetts General HospitalOTHER | 0 | Aug 10, 2009 | clinicaltrials |
| NCT00585845 | Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment | terminated | Phase 1 | 17 | Anza Therapeutics, Inc.INDUSTRY | 2 | Feb 20, 2009 | clinicaltrials |
| NCT00621556 | Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas | terminated | Phase 1 | 2 | Massachusetts General HospitalOTHER | 1 | Jan 29, 2009 | clinicaltrials |
| NCT00358566 | GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer | terminated | Phase 3 | 360 | Pharmexa A/SINDUSTRY | 12 | May 19, 2008 | clinicaltrials |
| NCT00249301 | A Study of MLN8054 in Patients With Advanced Solid Tumors | terminated | Phase 1 | 63 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00121745 | Evaluation of Safety of Rexin-G Gene Transfer for Advanced Pancreatic Cancer | terminated | Phase 1 | 12 | Epeius BiotechnologiesINDUSTRY | 1 | Dec 20, 2007 | clinicaltrials |
| NCT00116389 | Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas | terminated | Phase 2 | 60 | Point TherapeuticsINDUSTRY | 1 | Jun 8, 2007 | clinicaltrials |
| NCT00179751 | A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas | terminated | Phase 1 / Phase 2 | 50 | Celgene CorporationINDUSTRY | 1 | Nov 7, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Jul 19, 2011source: clinicaltrials